CONTEXT International differences in compliance of patients undergoing hemodialysis are poorly characterized and could contribute to international survival differences. OBJECTIVE To compare international differences in patient compliance with hemodialysis treatments. DESIGN A prospective observational study of patients undergoing hemodialysis in 1995 and a cross-sectional survey of health c...

background: chronic kidney disease is a health problem in today’s world and hemodialysis is an alternative method for patients with chronic renal failure. preparing provincial and national information on the situation of patients can play a significant role in improving the quality of services provided to patients undergoing hemodialysis. objective: this study aimed to investigate the character...

occult hbv infection of hemodialysis (hd) patients is informative in terms of virus transmission. it may be of clinical importance in hd patients. the aim of this study was to investigate the prevalence of anti-hbc in the hd patients. number of 126 patients undergoing hemodialysis were included in this study from main hemodialysis units in yazd. hepatitis b surface antigens (hbsag), hepatitis b...

conclusions the frequency of rls among our patients was remarkable and we conclude that all patients who are undergoing hemodialysis should be screened for rls, which can assist in providing proper attention and treatment. results according to our results, 54.5% of patients were diagnosed with rls, and of those 65.2% and 42.9% were women and men, respectively. rls is seen more often among patie...

We investigated the rates and predictors of mortality in hepatocellular carcinoma (HCC) patients who were or were not undergoing long-term hemodialysis. The participants in this retrospective observational study were 1298 HCC patients (60.0 ± 12.1 years old, 72% male), of whom 172 were undergoing hemodialysis and 1126 were not. HCC patients on hemodialysis exhibited a higher hepatitis C virus c...

The renin-angiotensin-aldosterone system (RAAS) blockers have been widely used in chronic kidney disease patients undergoing hemodialysis; however, whether RAAS blockers have beneficial effects for cardiovascular disease in those patients has not been fully defined. This review focuses on the effects of RAAS blockers in chronic kidney disease undergoing hemodialysis for cardiovascular disease.

Little is known about raltegravir removal by hemodialysis in patients with end-stage renal disease (ESRD). We therefore measured raltegravir concentrations in plasma in pre- and postdialyzer blood samples from 2 ESRD HIV-infected patients. The hemodialysis extraction ratio and raltegravir hemodialysis clearance were 5.5% and 9.1 ml/min in patient 1 and 9.5% and 19.1 ml/min in patient 2, respect...

Continuous Hemofiltration in the Perioperative Management for Chronic Hemodialysis Patients Undergoing Coronary Artery Bypass Surgery Shigeyuki Makino, Takane Hiraiwa, Toshihiko Kinoshita and Hideki Fujii (Department of Thoracic Surgery, Anjo Kosei Hospital, Aichi, Japan) Coronary artery bypass surgery was performed in 7 chronic hemodialysis patients. Hemodialysis and extracorporeal ultrafiltra...